Subscribe for stories that matter!
Warrington-based Windtree Therapeutics is currently exploring strategic alternatives to enhance shareholder value, including the possibility of acquisitions or being acquired, writes John George for…
Warrington-based biopharmaceutical firm Windtree Therapeutics is entering a multimillion-dollar licensing deal with a Chinese drug company for its three new cardiovascular disease drug…
The stock market’s January high is as distant a memory as New Year resolutions and wind chill reports. Since the start of June, performance…
A Phase 2 test by Windtree Therapeutics of its drug treatment for Associated Acute Respiratory Distress Syndrome (ARDS) may hold hope for patients with damaged…
Warrington-based Windtree Therapeutics, a biotechnology and medical device company, has appointed Joseph Soffer, M.D., F.A.C.C., as its new Executive Director…
Before we send you to this site, please subscribe to our daily newsletter.